1CT Institute of Pharmaceutical Sciences , Shahpur Campus, Jalandhar
2Chameli Devi Institute of Pharmacy, India
*Corresponding author: Surya Prakash Gautam, CT Institute of Pharmaceutical Sciences , Shahpur Campus, Jalandhar
Submission: June 12, 2019;Published: July 01, 2019
ISSN: 2576-8816Volume7 Issue5
Dendrimers has proved to be the molecule of the millennium. It acclaimed to this fascinating position is in the nanoworld. Despite of short history of nearly three decades, it has proved itself in the market as dendrimers-based products are contributing significantly and efficiently. Top leaders and Pharma giant companies are further strengthening their global presence by launching dendrimer-based products. Star pharma solely dedicated to dendrimers-based product have launched couple of products in the market and many more are in clinical trials. Scientists actively involved in research, number of patents filed every year; new drug applications submitted to FDA are witnessing and forecasting the future of dendrimers. Dendrimers if trusted will surely address the challenges of medical science. Dendrimers may address the problems in healthcare and feasibly our beloved ones may live long, or we may provide them the better quality of life.
Keywords: Clinical trial; Dendrimers; Drug Delivery; Nanoworld; Targeted